Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):332–338. doi: 10.1097/QAI.0000000000001224

Table 2.

GDS, IHDS and HAND classification in the HIV+ and HIV− groups

Variable HIV− (n=48) HIV+ (n=60) Cohen’s d2 P value
GDS1 0.23 (0.28) 0.87 (0.90) 0.96 <0.001
GDS ≥ 0.5 11 (23%) 36 (60%) <0.001
HAND
 normal 24 (40%) –
 ANI 29 (48.3%) –
 MND 2 (3.3%) –
 HAD 5 (8.3%) –
IHDS Total1 11.5(0.8) 10.4 (2.4) −0.62 0.001
IHDS Motor1 3.8 (0.4) 3.5 (0.8) −0.53 0.006
IHDS Speed1 3.9 (0.3) 3.4 (1.1) −0.67 <0.001
IHDS Recall1 3.8 (0.6) 3.6 (0.8) −0.33 0.096
1

mean (SD);

2

Groups differences presented as Cohen’s d effect sizes.

Note: ANI = Asymptomatic Neurocognitive Impairment; MND = Minor Neurocognitive Disorder; HAD = HIV-associated dementia.